BLFS  valuation analysis

Basics
Name: BioLife Solutions Inc
Description: BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. (more)
Industry: Medical Instruments & Supplies
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Feb 28, 2022
Market cap: $993.45M (1274th)
Sales(TTM): $119.16M (1401st)
Earnings(TTM): -$8.38M (1276th)

Value
FFER: 0.94*
Actual price: $22.93
* Earnings were reported May 11, 2022 but we do not have the financials for this quarter. This is likely because the company has not yet released them. However, it might also be a problem with data quality. Regardless, you should take the FFER above with a grain of salt until we get updated financials.

Prices as of EOD 2022-03-17
Price & Estimates
Sales & Earnings history (TTM)
Notable
  • BioLife Solutions Inc's sales grew by 169.5% ($44.22M to $119.16M) over one year against a market average growth of 24.0%.
Earnings / MarketCap
BioLife Solutions Inc
"Medical Instruments & Supplies" industry
Sales / MarketCap
BioLife Solutions Inc
"Medical Instruments & Supplies" industry
Book / MarketCap
BioLife Solutions Inc
"Medical Instruments & Supplies" industry
Equity / Assets
BioLife Solutions Inc
"Medical Instruments & Supplies" industry